Related Experiment Videos
Mechanisms, prevention and treatment of distal embolization
Italo Porto1, Giovanni Luigi De Maria, Maurizio Pieroni
1Cardiovascular Department, San Donato Hospital, Via Pietro Nenni 22 - 52100 Arezzo, Italy. italo.porto@gmail.com
Insights
Distal embolization (DE) during percutaneous coronary intervention (PCI) varies by condition. This review examines DE mechanisms and strategies for prevention and treatment in acute coronary syndromes (ACS) and stable coronary artery disease (CAD).
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Biology
Background:
- Distal embolization (DE) is a complication of percutaneous coronary intervention (PCI), also occurring spontaneously.
- The characteristics of embolized material differ between acute coronary syndromes (ACS) and stable coronary artery disease (CAD).
- DE is linked to elevated cardiac biomarkers, adverse left ventricular remodeling, and poorer patient prognosis.
Purpose of the Study:
- To review the mechanisms underlying distal embolization (DE).
- To discuss current and emerging strategies for the prevention and treatment of DE.
- To differentiate approaches for DE in the contexts of ACS and stable CAD.
Main Methods:
- Literature review of studies on distal embolization (DE).
- Analysis of mechanisms, composition, and clinical impact of DE.
- Synthesis of prevention and treatment strategies in interventional cardiology.
Main Results:
- DE mechanisms and emboli composition vary based on clinical presentation (ACS vs. stable CAD).
- DE is associated with adverse cardiac remodeling and a poor prognosis.
- Prevention and treatment strategies are critical but debated topics in interventional cardiology.
Conclusions:
- Understanding DE mechanisms is key to developing effective prevention and treatment strategies.
- Tailored approaches are needed for DE in ACS versus stable CAD.
- Further research into DE management is essential for improving outcomes in interventional cardiology.
Abstract:
Distal embolization (DE) can be either spontaneous or iatrogenic, occurring during percutaneous coronary intervention (PCI). The nature, composition and biochemical properties of embolized material differ according to the setting in which DE occurs: acute coronary syndromes (ACS) or stable coronary artery disease (CAD). DE occurrence is related to increased cardiac biomarkers, negative left ventricular remodeling and associated with a poor prognosis. Prevention and treatment of DE represent some of the most debated topics in interventional cardiology. This review paper is focused on mechanisms of DE and on the strategies for its prevention and treatment in both ACS and stable CAD.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction